CH575014A5
(US20070167479A1-20070719-C00034.png)
|
1973-05-25 |
1976-04-30 |
Alusuisse |
|
JPS5328498Y2
(US20070167479A1-20070719-C00034.png)
|
1973-08-17 |
1978-07-18 |
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
BR9204244A
(pt)
|
1992-10-26 |
1994-05-03 |
Cofap |
Ferro fundido cinzento
|
EP0671951A4
(en)
|
1992-12-01 |
1997-05-21 |
Protein Design Labs Inc |
HUMANIZED ANTIBODIES REACTING WITH L-SELECTIN.
|
US5876950A
(en)
|
1995-01-26 |
1999-03-02 |
Bristol-Myers Squibb Company |
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
|
FR2729855A1
(fr)
|
1995-01-26 |
1996-08-02 |
Oreal |
Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
|
ES2233974T3
(es)
|
1995-09-11 |
2005-06-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
CN1241944A
(zh)
|
1996-12-05 |
2000-01-19 |
乔治敦大学 |
具有抗病毒活性的鼠尾草种类的提取物
|
JPH11101542A
(ja)
|
1997-09-29 |
1999-04-13 |
Sanyo Electric Co Ltd |
冷蔵庫
|
CA2326755A1
(en)
|
1998-04-30 |
1999-11-04 |
Tanox, Inc. |
G-csf receptor agonist antibodies and screening method therefor
|
FR2780062B1
(fr)
|
1998-06-17 |
2000-07-28 |
Rhone Poulenc Rorer Sa |
Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
|
AU759689B2
(en)
|
1998-06-24 |
2003-04-17 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor proteins
|
EP1051432B1
(en)
|
1998-12-08 |
2007-01-24 |
Biovation Limited |
Method for reducing immunogenicity of proteins
|
EP1188830B1
(en)
|
1999-06-02 |
2010-01-20 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein ,nr10
|
AU7445900A
(en)
|
1999-09-27 |
2001-04-30 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein, nr12
|
CN1326880A
(zh)
|
2000-06-06 |
2001-12-19 |
周伟中 |
双层站台火车站
|
US20030096339A1
(en)
|
2000-06-26 |
2003-05-22 |
Sprecher Cindy A. |
Cytokine receptor zcytor17
|
PT1325115T
(pt)
|
2000-06-26 |
2016-09-28 |
Zymogenetics Inc |
Recetor de citocina zcytor17
|
WO2002077230A1
(fr)
|
2001-03-26 |
2002-10-03 |
Chugai Seiyaku Kabushiki Kaisha |
Variants d'epissage nr10
|
NZ528483A
(en)
|
2001-04-05 |
2008-03-28 |
Astellas Pharma Inc |
Anti-osteopontin antibody and use thereof
|
PT1576112E
(pt)
|
2002-01-18 |
2012-05-25 |
Zymogenetics Inc |
Multímeros de receptor de citocina zcytor17
|
CN100575482C
(zh)
|
2002-01-18 |
2009-12-30 |
津莫吉尼蒂克斯公司 |
新的细胞因子zcytor17配体
|
ATE431406T1
(de)
|
2002-02-25 |
2009-05-15 |
Genentech Inc |
Neuer typ-1-cytokinrezeptor glm-r
|
MXPA04010795A
(es)
|
2002-05-01 |
2005-03-07 |
Schering Ag |
Nuevos anticuerpos dirigidos al factor tisular como anticoagulantes.
|
US7579000B2
(en)
|
2002-05-01 |
2009-08-25 |
Bayer Schering Pharma Ag |
Tissue factor targeted antibodies as anticoagulants
|
TW200407335A
(en)
|
2002-07-22 |
2004-05-16 |
Chugai Pharmaceutical Co Ltd |
Non-neutralizing antibody to inhibit the inactivation of activated protein C
|
KR100499989B1
(ko)
|
2002-12-27 |
2005-07-07 |
네오바이오다임 주식회사 |
아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 면역크로마토그래피 스트립 및 이 스트립를 이용한 아사이알로 α1-산 당단백질 측정방법
|
US20040223970A1
(en)
|
2003-02-28 |
2004-11-11 |
Daniel Afar |
Antibodies against SLC15A2 and uses thereof
|
WO2004091543A2
(en)
|
2003-03-04 |
2004-10-28 |
Alexion Pharmaceuticals, Inc. |
Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
|
EP1606316A2
(en)
|
2003-03-24 |
2005-12-21 |
ZymoGenetics, Inc. |
Anti-il-20 antibodies and binding partners and methods of using in inflammation
|
WO2005079566A2
(en)
|
2004-02-12 |
2005-09-01 |
Lexicon Genetics Incorporated |
Gene disruptions, compositions and methods relating thereto
|
KR100624013B1
(ko)
|
2004-06-25 |
2006-09-19 |
주식회사 녹십자홀딩스 |
동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
|
EP1773391A4
(en)
|
2004-06-25 |
2009-01-21 |
Medimmune Inc |
INCREASING THE PRODUCTION OF RECOMBINANT ANTIBODIES IN MAMMALIAN CELLS BY MUTAGENESIS ON THE SITE
|
EP1671642A1
(en)
|
2004-12-15 |
2006-06-21 |
Universite D'angers |
Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
|
CA2591059C
(en)
|
2004-12-28 |
2018-11-06 |
Innate Pharma |
Monoclonal antibodies against nkg2a
|
ES2579758T3
(es)
|
2005-01-28 |
2016-08-16 |
Zymogenetics, Inc. |
Preparaciones homogéneas de IL-31
|
US20060182743A1
(en)
|
2005-02-14 |
2006-08-17 |
Janine Bilsborough |
Methods of treating skin disorders using an IL-31RA antagonist
|
WO2006088955A2
(en)
|
2005-02-14 |
2006-08-24 |
Zymogenetics, Inc. |
Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
CN101198624B
(zh)
*
|
2005-05-06 |
2012-10-10 |
津莫吉尼蒂克斯公司 |
Il-31单克隆抗体及使用方法
|
AU2007249713A1
(en)
|
2006-01-10 |
2007-11-22 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using IL-31Ra and OSMRb antagonists
|
ES2586825T3
(es)
|
2006-01-12 |
2016-10-19 |
Alexion Pharmaceuticals, Inc. |
Anticuerpos para OX-2/CD200 y usos de los mismos
|
CN101421303B
(zh)
|
2006-03-23 |
2013-06-12 |
生命北极神经科学公司 |
改进的初原纤维选择性抗体及其用途
|
DK2047863T3
(da)
|
2006-06-08 |
2013-09-16 |
Chugai Pharmaceutical Co Ltd |
Middel til forebyggelse eller behandling af inflammatoriske sygdomme
|
ES2415655T3
(es)
|
2006-06-15 |
2013-07-26 |
The Board Of Trustees Of The University Of Arkansas |
Anticuerpos monoclonales que reconocen selectivamente Metanfetamina y compuestos similares a Metanfetamina
|
EP2759549B1
(en)
|
2006-09-01 |
2015-08-19 |
ZymoGenetics, Inc. |
IL-31 monoclonal antibodies and methods of use
|
RU2009120202A
(ru)
|
2006-12-11 |
2011-01-20 |
Вайет (Us) |
Способы и композиции для лечения и мониторинга лечения связанных с il-13 расстройств
|
CN101600456A
(zh)
*
|
2006-12-11 |
2009-12-09 |
惠氏公司 |
治疗il-13相关疾病和监测il-13相关疾病治疗的方法和组合物
|
EP2069404B1
(en)
|
2007-02-14 |
2011-01-05 |
Vaccinex, Inc. |
Humanized anti-cd100 antibodies
|
BRPI0807710B1
(pt)
|
2007-02-23 |
2021-12-14 |
Merck Sharp & Dohme Corp |
Anticorpos que se ligam a il-23p19 e il-23 humana, anticorpo, ácido nucleico isolado, vetor de expressão, célula hospedeira microbiana, método de produção de um polipeptídeo e composição farmacêutica
|
WO2008114733A1
(ja)
|
2007-03-16 |
2008-09-25 |
Kyowa Hakko Kirin Co., Ltd. |
抗Claudin-4抗体
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
WO2009007272A1
(en)
|
2007-07-10 |
2009-01-15 |
F. Hoffmann-La Roche Ag |
Novel formulation
|
MX369784B
(es)
*
|
2007-09-26 |
2019-11-21 |
Chugai Pharmaceutical Co Ltd |
Metodo de modificacion del punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
|
CL2008002885A1
(es)
|
2007-09-26 |
2010-07-02 |
Chugai Pharmaceutical Co Ltd |
Anticuerpo anti-receptor de interleucina-6 (il-6); y composicion farmaceutica que lo comprende
|
PH12018501459A1
(en)
|
2007-09-26 |
2019-11-11 |
Chugai Pharmaceutical Co Ltd |
Modified antibody constant region
|
EP2236604B1
(en)
|
2007-12-05 |
2016-07-06 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-nr10 antibody and use thereof
|
EP2241332A4
(en)
|
2007-12-05 |
2011-01-26 |
Chugai Pharmaceutical Co Ltd |
THERAPEUTIC AGENT AGAINST PRITURE
|
HUE036548T2
(hu)
|
2007-12-07 |
2018-08-28 |
Zymogenetics Inc |
IL-31-re specifikus humanizált antitest molekulák
|
KR20160062207A
(ko)
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항nr10 항체 및 그의 이용
|
JP2010210772A
(ja)
*
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
ES2569514T3
(es)
|
2009-06-17 |
2016-05-11 |
Biomarin Pharmaceutical Inc. |
Formulaciones para enzimas lisosómicas
|
WO2013012022A1
(ja)
|
2011-07-19 |
2013-01-24 |
中外製薬株式会社 |
アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
EP3889181B1
(en)
|
2012-09-07 |
2024-04-24 |
Regeneron Pharmaceuticals, Inc. |
An il-4r antagonist antibody for use in treating atopic dermatitis by administering
|
US9198898B2
(en)
*
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
TW201537175A
(zh)
|
2013-06-28 |
2015-10-01 |
Chugai Pharmaceutical Co Ltd |
預測罹患具皮膚搔癢之疾病的患者對il-31拮抗劑之治療的反應之方法
|
CA2980992C
(en)
|
2015-04-14 |
2024-01-23 |
Akihisa Kaneko |
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
|
WO2018156367A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
GB201703063D0
(en)
|
2017-02-24 |
2017-04-12 |
Arecor Ltd |
Stabilized antibody protein solutions
|
BR112019021364A2
(pt)
|
2017-04-11 |
2020-05-05 |
Kiniksa Phamaceuticals Ltd |
formulação estável de anticorpo anti-osmr
|
US20210196568A1
(en)
|
2018-05-21 |
2021-07-01 |
Chugai Seiyaku Kabushiki Kaisha |
Lyophilized formulation sealed in glass container
|
BR112022006590A2
(pt)
|
2019-11-20 |
2022-06-28 |
Chugai Pharmaceutical Co Ltd |
Preparação contendo anticorpos
|
CN116096411A
(zh)
|
2020-09-01 |
2023-05-09 |
中外制药株式会社 |
含有作为活性成分的il-31拮抗剂的用于预防和/或治疗透析瘙痒的药物组合物
|